Intra-Cellular Therapies, Inc. - Wutah pendapatan kuartal marang kuartal ITCI

Logo perusahaan publik Intra-Cellular Therapies, Inc. (ITCI)

Intra-Cellular Therapies (ITCI) generates revenue from the sale of prescription drugs for the therapy of psychiatric pathologies. Quarterly sales growth trends confirm the business's resilience, where 50.80 shapes the current metric. Growth is driven by the success of Caplyta in treating depressive disorders. High patient brand loyalty minimizes risks, creating a robust ecosystem with an intensive influx of new prescriptions.

Intra-Cellular Therapies (ITCI) - Wutah pendapatan triwulanan saka 04.07.2022 nganti 13.04.2025

Ringkesan rincian data analitis Intra-Cellular Therapies (ITCI)

- kuotasi saiki lan rata-rata prakiraan nilai:
Analisis umum perusahaan:Intra-Cellular - ITCI
Produk sing diprodhuksi Intra-Cellular

Investors must balance capital protection against volatility with the risk of missed opportunities when searching for undervalued assets. By analyzing quarterly changes in sales volume, you evaluate the revenue growth rates of Intra-Cellular Therapies (ITCI), which is critical amid geopolitical raw material supply disruptions and drug registration delays, allowing for a determination of business resilience and the precise portfolio entry point.

Perusahaan pesaing

BIIB - Wutah pendapatan kuartal marang kuartal|NBIX (Neurocrine Biosciences) - Wutah dodolan kuartal marang kuartal|RGC: Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal Axsome (AXSM)|Wutah pendapatan kuartal marang kuartal ACADIA Pharmaceuticals Inc|Wutah dodolan triwulanan Xenon Pharmaceuticals Inc (XENE)|Wutah pendapatan triwulanan VKTX|Wutah pendapatan triwulanan supernus.com (SUPN)|Wutah pendapatan kuartal marang kuartal Catalyst Pharmaceuticals, Inc. CPRX|DNLI (Denali Therapeutics Inc.) - Dinamika pendapatan kuartal marang kuartal|Harmony Corp - Wutah pendapatan triwulanan|BHVN: Wutah pendapatan kuartal marang kuartal|AMLX: Wutah pendapatan triwulanan|TRVI: Owah-owahan dodolan kuartal marang kuartal|Wutah pendapatan kuartal marang kuartal Praxis Medicines|Tingkat wutah pendapatan sajrone kuartal Anavex AVXL|Wutah pendapatan kuartal marang kuartal CeriBell Corp (CBLL)|Owah-owahan dodolan kuartal marang kuartal PRTA|Wutah pendapatan triwulanan ALEC (Alector)|Annexon (ANNX) - Tingkat wutah pendapatan sajrone kuartal|OMER - Wutah pendapatan kuartal marang kuartal|NGNE (Neurogene) - Wutah dodolan kuartal marang kuartal|ACIU: Wutah pendapatan triwulanan|VYGR - Tingkat wutah dodolan sajrone kuartal|Wutah pendapatan kuartal marang kuartal Neumora Therapeutics, Inc.|Wutah dodolan kuartal marang kuartal SCLX (Scilex)|Wutah dodolan triwulanan TVGN (Tevogen Bio)|Wutah pendapatan triwulanan Alpha Cognition Inc (ACOG)|Wutah pendapatan triwulanan CGTX (cogrx.com)|Tingkat wutah dodolan sajrone kuartal Inhibikase Pharma (IKT)|SAVA: Wutah dodolan triwulanan|Tingkat wutah dodolan sajrone kuartal Assertio ASRT|COYA (coyatherapeutics.com) - Wutah dodolan triwulanan|Wutah dodolan kuartal marang kuartal VTGN|OVID (Ovid Therapeutics) - Wutah pendapatan triwulanan|Acumen Pharmaceuticals, Inc (ABOS) - Tingkat wutah dodolan sajrone kuartal|Wutah pendapatan kuartal marang kuartal CervoMed, Inc. (CRVO)|ATHE - Tingkat wutah pendapatan sajrone kuartal|Wutah pendapatan triwulanan CLNN (Clene Inc.)|Tingkat wutah dodolan sajrone kuartal PepGen Inc. (PEPG)|JUNS - Wutah pendapatan kuartal marang kuartal|Tingkat wutah pendapatan sajrone kuartal Relmada Corp|ANVS (Annovis Bio, Inc.) - Wutah dodolan triwulanan|Grace Tx (GRCE) - Wutah pendapatan triwulanan|Wutah dodolan triwulanan AIFF|Wutah pendapatan triwulanan anewmeds.com|Wutah pendapatan kuartal marang kuartal NeuroSense Therapeutics (NRSN)|RVPH (Reviva Pharmaceuticals Holdings) - Tambahing pendapatan triwulanan|MetaVia - Wutah dodolan triwulanan|NRXS: Wutah dodolan kuartal marang kuartal|Helius Medical Technologies, Inc. - Wutah pendapatan triwulanan|PASG: Wutah pendapatan kuartal marang kuartal|Neuphoria (NEUP) - Wutah pendapatan kuartal marang kuartal|Minerva Neurosciences - Tambahing pendapatan triwulanan|ATHA (Athira Pharma, Inc.) - Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal addextherapeutics.com ADXN|Wutah dodolan triwulanan ALZN (Alzamend Neuro Inc.)|CYCN (Cyclerion Therapeutics, Inc.) - Tambahing pendapatan triwulanan|Wutah pendapatan triwulanan PTIX (Protagenic)|Wutah pendapatan triwulanan pasitheaclinics.com KTTA|CRGT - Wutah pendapatan kuartal marang kuartal|Tambahing pendapatan triwulanan ATXI (Avenue Therapeutics)|BCLI: Wutah pendapatan triwulanan|Cara Therapeutics - Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal Chromocell Therapeutics Corporation|Wutah pendapatan triwulanan Eliem Therapeutics Inc.|Wutah pendapatan kuartal marang kuartal Longboard Pharmaceuticals (LBPH)|MRNS (Marinus Pharmaceuticals) - Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal NKGen NKGN|Wutah pendapatan triwulanan NeuroBo Pharmaceuticals Inc NRBO|SAGE: Wutah dodolan triwulanan|Tingkat wutah dodolan sajrone kuartal Synaptogenix, Inc SNPX|TRVN: Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal Vigil Neuroscience (VIGL)|Wutah pendapatan kuartal marang kuartal Anew Medical, Inc.|CERE (Cerevel Therapeutics, Inc.) - Owah-owahan dodolan kuartal marang kuartal